CompletedNot applicableNCT06341127

Fluoxetine in KCNC1-related Disorder

Studying Rare genetic disease

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Holland Bloorview Kids Rehabilitation Hospital
Principal Investigator
Danielle Baribeau, MD, PhD
Holland Bloorview Kids Rehabilitation Hospital
Intervention
Fluoxetine(drug)
Enrollment
1 enrolled
Eligibility
18 years · All sexes
Timeline
20242024

Study locations (1)

Collaborators

The Hospital for Sick Children

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06341127 on ClinicalTrials.gov

Other trials for Rare genetic disease

Additional recruiting or active studies for the same condition.

See all trials for Rare genetic disease

← Back to all trials